RxHealth™ Raises $1.8 Million Seed Round, Launches Bulk Prescription™ to Population Health Programs
Digital medicine platform Rx.Health, a Mount Sinai Health System spinoff and provider of RxUniverse™, recently announced that it has raised $1.8 million in seed funding. The funding will be used to diversify Rx.Health’s client base and support its first-to-market Bulk Prescription™ digital …
Mount Sinai and Novotalk sign a joint venture agreement to bring innovative speech and language therapeutic technologies to patients
On-demand (virtual) health solutions enable the patient to undergo a therapeutic process with a computer acting as a virtual clinician • The licensed clinicians supervise the process, leveraging mass data collection for clinical insights not otherwise available in a regular clinical setting …
Erik Lium, PhD, Promoted to Executive Vice President of Mount Sinai Innovation Partners
The Mount Sinai Health System has announced Erik Lium, PhD, has been promoted to Executive Vice President of Mount Sinai Innovation Partners (MSIP). His new, expanded role will include broad responsibilities for innovation, commercialization, and entrepreneurship across the Mount Sinai Health System …
The Pioneers of Kidney Disease Prevention: Meet Mount Sinai Nephrologists Steven Coca and Girish Nadkarni
As colleagues in Mount Sinai’s Division of Nephrology, Steven Coca, DO, MS and Girish Nadkarni, MD, MPH share a mutual passion for revolutionizing chronic kidney disease management on a global scale. Drs. Coca and Nadkarni are the co-inventors of KidneyTrackTM, an artificial …
Mount Sinai and RenalytixAI Launch Groundbreaking Artificial Intelligence Solution For Improved Kidney Disease Management and Patient Care
Artificial Intelligence (AI) will be deployed against Mount Sinai’s massive patient data warehouse biorepository and to innovate more accurate disease detection and management for introduction in 2019 Kidney disease is a public health crisis affecting an estimated 12% or 120 million of …
Mount Sinai Launches the i3 Asset Accelerator to Advance the Development of Life-Saving Discoveries
The Icahn School of Medicine at Mount Sinai and Mount Sinai Innovation Partners today announced the launch of the i3 Asset Accelerator, a new fund that fast-tracks select research discoveries to reach patients sooner, and has selected its first two projects to …
Ground-breaking Collaboration pursues the early detection of Endometrial and Ovarian Cancers
Mirage News: New York City-based Icahn School of Medicine at Mount Sinai and Adelaide, South Australia-based Numedico Technologies, have signed a Collaboration Development Agreement (CDA). The international collaboration team will design, develop and commercialise a device for the screening and early detection of …
Mount Sinai Health System Top 10 Researchers
It’s our pleasure to introduce the Top 10 Mount Sinai researchers who have shared their discoveries with MSIP in the form of a Technology Disclosure, a written description of the inventor(s) technology. Disclosures allow MSIP to survey the landscape of translational discoveries …
ShangPharma Innovation And Icahn School Of Medicine At Mount Sinai Forge Translational Research Collaboration
Medical Health News ShangPharma Innovation Inc., a global venture capital firm focused on biomedical R&D therapeutics and technologies, and the Icahn School of Medicine at Mount Sinai has entered into a multi-year strategic collaboration to accelerate the development of novel early-stage therapeutics. …